Genmab A/S (ETR:GE9)
Germany · Delayed Price · Currency is EUR 246.00
-0.30 (-0.12%)
At close: Nov 7, 2025
Genmab Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 3,846 | 2,988 | 2,443 | 2,084 | 1,287 | 1,662 | Upgrade | |
Revenue Growth (YoY) | 29.57% | 22.32% | 17.23% | 61.88% | -22.52% | 106.20% | Upgrade |
Cost of Revenue | 216.74 | 136.74 | 33.52 | - | - | - | Upgrade |
Gross Profit | 3,629 | 2,852 | 2,410 | 2,084 | 1,287 | 1,662 | Upgrade |
Selling, General & Admin | 643.4 | 526.14 | 488.94 | 384.48 | 196.24 | 108.63 | Upgrade |
Research & Development | 1,567 | 1,343 | 1,132 | 799.14 | 639.51 | 515.54 | Upgrade |
Operating Expenses | 2,211 | 1,869 | 1,620 | 1,184 | 835.75 | 624.17 | Upgrade |
Operating Income | 1,418 | 982.72 | 789.09 | 900.43 | 451.68 | 1,037 | Upgrade |
Interest Expense | -25.85 | -16.66 | -10.38 | -5.6 | -1.99 | -1.64 | Upgrade |
Interest & Investment Income | 134.31 | 138.13 | 145.63 | 46.55 | 30.13 | 30.24 | Upgrade |
Currency Exchange Gain (Loss) | 185.35 | 185.88 | -131.84 | 151.01 | 224.85 | -239.28 | Upgrade |
EBT Excluding Unusual Items | 1,712 | 1,290 | 792.5 | 1,092 | 704.67 | 826.8 | Upgrade |
Merger & Restructuring Charges | -8.13 | -41.65 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | 87.8 | 34.29 | 43.45 | -94.54 | -105.39 | 143.47 | Upgrade |
Asset Writedown | -11.94 | -10.55 | - | - | - | - | Upgrade |
Pretax Income | 1,780 | 1,272 | 835.95 | 997.85 | 599.28 | 970.27 | Upgrade |
Income Tax Expense | 196.37 | 183.25 | 190.56 | 214.51 | 146.99 | 188.34 | Upgrade |
Net Income | 1,583 | 1,089 | 645.39 | 783.33 | 452.29 | 781.94 | Upgrade |
Net Income to Common | 1,583 | 1,089 | 645.39 | 783.33 | 452.29 | 781.94 | Upgrade |
Net Income Growth | 125.14% | 68.72% | -17.61% | 73.19% | -42.16% | 140.38% | Upgrade |
Shares Outstanding (Basic) | 63 | 64 | 65 | 65 | 65 | 65 | Upgrade |
Shares Outstanding (Diluted) | 63 | 65 | 66 | 66 | 66 | 66 | Upgrade |
Shares Change (YoY) | -3.12% | -1.94% | -0.14% | -0.06% | 0.24% | 3.53% | Upgrade |
EPS (Basic) | 25.24 | 16.96 | 9.88 | 11.98 | 6.92 | 12.00 | Upgrade |
EPS (Diluted) | 25.10 | 16.85 | 9.79 | 11.87 | 6.85 | 11.87 | Upgrade |
EPS Growth | 132.41% | 72.08% | -17.49% | 73.29% | -42.30% | 132.20% | Upgrade |
Free Cash Flow | 1,328 | 1,053 | 1,040 | 516.52 | 302.24 | 1,007 | Upgrade |
Free Cash Flow Per Share | 21.06 | 16.29 | 15.78 | 7.83 | 4.58 | 15.28 | Upgrade |
Gross Margin | 94.36% | 95.42% | 98.63% | 100.00% | 100.00% | 100.00% | Upgrade |
Operating Margin | 36.88% | 32.89% | 32.30% | 43.21% | 35.08% | 62.44% | Upgrade |
Profit Margin | 41.17% | 36.44% | 26.42% | 37.59% | 35.13% | 47.06% | Upgrade |
Free Cash Flow Margin | 34.54% | 35.23% | 42.58% | 24.79% | 23.48% | 60.59% | Upgrade |
EBITDA | 1,466 | 1,026 | 819.93 | 941.81 | 481.35 | 1,075 | Upgrade |
EBITDA Margin | 38.12% | 34.33% | 33.56% | 45.19% | 37.39% | 64.71% | Upgrade |
D&A For EBITDA | 47.86 | 43.17 | 30.85 | 41.38 | 29.67 | 37.8 | Upgrade |
EBIT | 1,418 | 982.72 | 789.09 | 900.43 | 451.68 | 1,037 | Upgrade |
EBIT Margin | 36.88% | 32.89% | 32.30% | 43.21% | 35.08% | 62.44% | Upgrade |
Effective Tax Rate | 11.03% | 14.40% | 22.80% | 21.50% | 24.53% | 19.41% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.